Article

Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19

2021-08-29

Abstract excerpt

The great majority of SARS-CoV-2 infections are mild and uncomplicated, but some individuals with initially mild COVID-19 progressively develop more severe symptoms. Furthermore, mild to moderate infections are an important contributor to ongoing transmission. There remains a critical need to identify host immune biomarkers predictive of clinical and virologic outcomes in SARS-CoV-2-infected patients. Leveraging l...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7813a6d3-e8c8-5f92-9d51-1555741d94f3
DOI: 10.1101/2021.08.27.21262687

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19DOI 10.1101/2021.08.27.21262687Read

Early immune responses have long-term associations with clinical, virologic, and immunologic outcomes in patients with COVID-19Semantic proximity Read

Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistenceSemantic proximity Read

Enhanced inflammation and suppressed adaptive immunity in COVID-19 with prolonged RNA sheddingSemantic proximity Read

Immunological and clinical markers of post-acute sequelae of COVID-19: Insights from mild and severe cases six months post-infectionSemantic proximity Read

Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection TrajectoriesSemantic proximity Read

Heterogeneous immunological recovery trajectories revealed in post-acute COVID-19Semantic proximity Read

Multiomic Immunophenotyping of COVID-19 Patients Reveals Early Infection TrajectoriesSemantic proximity Read

Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine LearningSemantic proximity Read

Immunological and Clinical Markers of Post‐acute Sequelae of COVID‐19: Insights from Mild and Severe Cases 6 Months Post‐infectionSemantic proximity Read

Data-driven analysis of COVID-19 reveals specific severity patterns distinct from the temporal immune responseSemantic proximity Read

Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanismSemantic proximity Read

Early Fc-effector antibody signatures impact COVID-19 disease trajectorySemantic proximity Read